SA
Sanofi India Limited
SANOFI.BO · BSE
₹3,082.10 -0.80% (-₹24.90)
1M -5.13%
Market Cap ₹71.7B
P/E Ratio 22.14x
Div. Yield -
ROE 40.25%
Bulios Fair Price
₹2,103
31.8% downside
Current Price
₹3,082
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SANOFI.BO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
31 /100
Expensive P/FCF 51.84x
P/E 22.14x
P/B 8.68x
Growth
11 /100
Declining FCF growth 4.14%
EPS growth 19.26%
Book val. growth 16.26%
Profitability
82 /100
Strong Op. margin 24.71%
Gross margin 41.03%
FCF margin 7.66%
Quality
100 /100
Excellent ROA 23.01%
ROIC 39.43%
Asset turnover 1.28x
Debt
98 /100
Low Int. coverage 273.19x
Debt/Equity 0.02x
Net debt/EBITDA -0.73x
Stability
61 /100
Moderate EPS volatility 22.85%
Beta 0.20x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SANOFI.BO
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Deepak Arora
Employees
1,097
Headquarters
Mumbai
Upcoming events
29 OCT
Earnings
Upcoming earnings report